Cargando…
Ligand-directed labeling of opioid receptors for covalent attachment of fluorophores or small-molecule probes
This protocol describes endogenous labeling of opioid receptors (ORs) using a ligand-directed reagent, naltrexamine-acylimidazole compounds (NAI-X). NAI acts by guiding and permanently tagging a small-molecule reporter (X)—such as fluorophores or biotin—to ORs. Here we detail syntheses and uses of N...
Autores principales: | Adoff, Hayden, Halls, Victoria S., Holland, Emily, Lobingier, Braden, Arttamangkul, Seksiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154970/ https://www.ncbi.nlm.nih.gov/pubmed/37104091 http://dx.doi.org/10.1016/j.xpro.2023.102231 |
Ejemplares similares
-
Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores
por: Kirmeier, Thomas, et al.
Publicado: (2016) -
Functional independence of endogenous μ- and δ-opioid receptors co-expressed in cholinergic interneurons
por: Arttamangkul, Seksiri, et al.
Publicado: (2021) -
Cellular tolerance at the µ-opioid receptor is phosphorylation dependent
por: Arttamangkul, Seksiri, et al.
Publicado: (2018) -
Visualizing endogenous opioid receptors in living neurons using ligand-directed chemistry
por: Arttamangkul, Seksiri, et al.
Publicado: (2019) -
An Efficient Site-Specific Method for Irreversible Covalent Labeling of Proteins with a Fluorophore
por: Liu, Jiaquan, et al.
Publicado: (2015)